Safety and immunogenicity after a 30month boost of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 MF59 vaccine boost HVTN 100 A phase 12 randomized doubleblind placebocontrolled trial
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
DOAJ